| Date | Time | Source | Headline | Symbol | Company |
| 11/04/2010 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/04/2010 | 4:00PM | Business Wire | Allos Therapeutics Reports Third Quarter 2010 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/26/2010 | 4:00PM | Business Wire | Allos Therapeutics to Report Third Quarter 2010 Financial Results on November 4, 2010 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/22/2010 | 5:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/15/2010 | 10:06AM | Dow Jones News | Allos Granted Orphan Status In Europe For Lymphoma Drug | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/15/2010 | 9:00AM | Business Wire | Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Hodgkin Lymphoma by the Eu... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2010 | 8:19AM | Dow Jones News | Allos' Pralatrexate Outperforms Tarceva In Lung-Cancer Study | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2010 | 7:15AM | Business Wire | Allos Therapeutics Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN® in Patients ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/04/2010 | 10:00AM | GlobeNewswire Inc. | Allos Therapeutics, Inc. (ALTH) to Ring The NASDAQ Stock Market Closing Bell | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/17/2010 | 4:14PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/17/2010 | 4:13PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/15/2010 | 5:40PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/15/2010 | 5:38PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/15/2010 | 5:37PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/15/2010 | 5:35PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/13/2010 | 9:00AM | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/09/2010 | 1:29PM | Business Wire | Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/03/2010 | 5:50PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/03/2010 | 5:49PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/02/2010 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/01/2010 | 4:19PM | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/25/2010 | 6:06AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/30/2010 | 4:17PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |